Woodline Partners’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-52,533
Closed -$471K 688
2023
Q3
$471K Buy
+52,533
New +$499K 0.01% 501
2022
Q2
Sell
-25,000
Closed -$318K 906
2022
Q1
$318K Hold
25,000
0.01% 532
2021
Q4
$524K Buy
+25,000
New +$505K 0.01% 548

Other funds holding ENFN

Woodline Partners's ENFN Position: Q4 2023 in Review

Woodline Partners sold out of Enfusion, Inc. (ENFN) in Q4 2023, closing a stake of 52,533 shares — an estimated $471K sold.

Woodline Partners first reported a position in ENFN in Q4 2021 and held it in 3 quarters. The position peaked at $524K in Q4 2021. 76 funds tracked by Wall St. Rank hold ENFN as of Q4 2023.

  • Woodline Partners reported no remaining Enfusion, Inc. position as of Q4 2023 after selling out during the quarter.
  • Woodline Partners sold 52,533 Enfusion, Inc. shares in Q4 2023, an estimated $471K.
  • Woodline Partners first reported a position in Enfusion, Inc. in Q4 2021 and held it in 3 quarters.
  • Woodline Partners's Enfusion, Inc. position peaked at $524K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2023.

Based on Woodline Partners's 13F filing for Q4 2023, filed 14 Feb 2024.